14.04.2021 • NewsExxonMobil

ExxonMobil May Sell Elastomers Business

Exxon Mobil is exploring a sale of its Advanced Elastomer Systems (AES) division, potentially valuing it at around $800 million including debt, Reuters has reported, citing people familiar with the matter.

A deal could help the energy and petrochemicals group pare down some of its debt burden, which had risen to $45.5 billion at the end of 2020. Exxon has reportedly hired investment bank Morgan Stanley to solicit interest from potential buyers, including private equity investors.

After an historic loss of $22.4 billion last year, the Texas, USA-based group is struggling to convince investors that it can potentially rebound after years of overspending and a much criticized lack of investment in cleaner fuels.

In elastomers, Exxon is known for its Santoprene-brand thermoplastic vulcanizates (TPVs) used in automotive, industrial and consumer products. This business was launched in 1991 as a limited partnership between ExxonMobil Chemical and Solutia, then a spinout of Monsanto. Exxon took full ownership of it in 2002.

The global TPV market is poised to grow from $1.6 billion in 2019 to $2.6 billion in 2027, according to a report by ResearchAndMarkets.com. However, the industry has been adversely affected by the Covid-19 pandemic due to plant shutdowns and supply chain issues.

Author: Dede Williams, Freelance Journalist

Exxon Mobil is exploring a sale of its Advanced Elastomer Systems (AES)...
Exxon Mobil is exploring a sale of its Advanced Elastomer Systems (AES) division, potentially valuing it at around $800 million including debt, Reuters said. A sale could help pare down a $45.5 billion debt burden. The group reported an historic loss of $22.4 billion last year. (c) Tasos Mansour

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read